Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
JAMA oncology 2019-05-01
Analysis of Toxic Effects With Antiangiogenic Agents Plus Stereotactic Body Radiation in Ultracentral Lung Tumors.
Related Questions
What are your recommendations for holding bevacizumab before and after SBRT to the lung?
4861
×
To continue please login or register
Register
or
Sign in
